AGM on Sept 30, 2016
Lincoln Pharmaceuticals Ltd has informed BSE that the 22nd Annual General Meeting (AGM) of the Company will be held on September 30, 2016.06-09-2016
06-09-2016
Fixes Book Closure for Dividend & AGM
Lincoln Pharmaceuticals Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from September 27, 2016 to September 30, 2016 (both days inclusive) for the purpose of Payment of Dividend & 22nd Annual General Meeting (AGM) of the Company to be held on September 30, 2016.06-09-2016
Lincoln Pharmaceuticals launches Vaginal Spray for "FIRST TIME IN INDIA"
Lincoln Pharmaceuticals Ltd has informed BSE regarding a Press Release titled "Lincoln Pharmaceuticals launches Vaginal Spray for "FIRST TIME IN INDIA"."02-09-2016
Earnings Presentation for June 30, 2016
Lincoln Pharmaceuticals Ltd has informed BSE about Earnings Presentation for the period ended June 30, 2016.17-08-2016
Results Press Release for June 30, 2016
Lincoln Pharmaceuticals Ltd has informed BSE about : 1. Result Press Release for the period ended June 30, 201611-08-2016
Standalone & Consolidated Financial Results, Limited Review Report for June 30, 2016
Lincoln Pharmaceuticals Ltd has informed BSE about : 1. Standalone Financial Results for the period ended June 30, 20162. Consolidated Financial Results for the period ended June 30, 20163. Standalone Limited Review for the period ended June 30, 20164. Consolidated Limited Review for the period ended June 30, 201611-08-2016
Board Meeting Intimation for Results & Closure of Trading Window
Lincoln Pharmaceuticals Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on August 11, 2016 to consider and approve the Quarterly Unaudited Financial Results for the aforesaid quarter and also to consider any other business, if any.In view of above, the trading window will remain dose for the Promoters, Directors, Insiders, Designated Persons and the Connected Persons from the date of this letter and...30-07-2016
Shareholding for the Period Ended June 30, 2016
Lincoln Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2016. For more details, kindly Click here20-07-2016
Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended June 30, 2016
Lincoln Pharmaceuticals Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended June 30, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.20-07-2016
Newspaper Advertisement regarding Appointment of RTA
Lincoln Pharmaceuticals Ltd has submitted to BSE a copy of the Notice informing the stakeholders of the Company regarding appointment of M/s. Link Intime India Private Limited as its new Registrar and Transfer Agent (R & TA) w.e.f. July 15, 2016 which is published by the Company in the newspapers.18-07-2016